ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
93,440.93
-1.11%
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs Yen
157.491
-0.26%
Brent Oil
80.505
-0.14%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. AnaptysBio Inc (ANAB)

  7. AnaptysBio Inc (ANAB) ニュース

ANAB

AnaptysBio (ANAB)

AnaptysBio Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ANAB
日付受信時刻ニュースソース見出しコード企業名
2025/01/0807 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2025/01/0807 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2025/01/0807 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2025/01/0807 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2025/01/0807 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2025/01/0807 : 27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2025/01/0723 : 15GlobeNewswire Inc.Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ANABAnaptysBio Inc
2025/01/0308 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/12/1906 : 30Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ANABAnaptysBio Inc
2024/12/1206 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2024/12/1122 : 30GlobeNewswire Inc.Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic DermatitisNASDAQ:ANABAnaptysBio Inc
2024/11/1814 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ANABAnaptysBio Inc
2024/11/1606 : 06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ANABAnaptysBio Inc
2024/11/1423 : 24Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ANABAnaptysBio Inc
2024/11/0606 : 27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANABAnaptysBio Inc
2024/11/0606 : 19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
2024/11/0606 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2024/11/0606 : 15GlobeNewswire Inc.Anaptys Announces Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ANABAnaptysBio Inc
2024/11/0606 : 15GlobeNewswire Inc.Anaptys Announces Participation in November and December Investor ConferencesNASDAQ:ANABAnaptysBio Inc
2024/09/2505 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/09/2405 : 16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANABAnaptysBio Inc
2024/09/1807 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/09/1807 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/08/2922 : 15GlobeNewswire Inc.Anaptys Announces Participation in September Investor ConferencesNASDAQ:ANABAnaptysBio Inc
2024/08/1705 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/08/1701 : 07Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ANABAnaptysBio Inc
2024/08/1701 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/08/1505 : 43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2024/08/1505 : 41Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ANABAnaptysBio Inc
2024/08/1505 : 34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANABAnaptysBio Inc
 Showing the most relevant articles for your search:NASDAQ:ANAB

最近閲覧した銘柄

NYSE
JPM
JP Morgan Chase
FX
USDEUR
US Dollar vs Euro
FX
USDJPY
US Dollar vs Yen
COIN
ETHUSD
Ethereum
NASDAQ
TSLA
Tesla
CCOM
US100
US Tech 100
AMEX
SPY
SPDR S&P 500
CCOM
US500
US 500
NYSE
BAC
Bank of America
NYSE
MRK
Merck
COIN
AVAXUSD
Avalanche
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有